Phenotypic differences of stroma cells in benign and malignant human prostate tissues

National Medical Journal of China

Volumn 92, Issue 8, 2012, Pages 516-519

  Zhou, Hui ^a   Sun, Hong Bin ^a   Huang, Wen Bin ^a   Xu, Zheng ^a   Su, Jiang Hao ^a   Zhu, Jia Geng ^a   Jia, Rui Peng ^a   Liu, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Benign prostate hyperplasia; Myofibroblast; Prostate neoplasms; Stroma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; VIMENTIN;

ADVANCED CANCER; ARTICLE; CANCER TISSUE; CELL VOLUME; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYOFIBROBLAST; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STROMA CELL;

ACTINS; AGED; AGED, 80 AND OVER; DESMIN; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; STROMAL CELLS; VIMENTIN;

EID: 84867931109     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.08.005     Document Type: Article

References (11)

1. 2007, 28:605-608.
2. Ayala G, Tuxhorn J A, Wheeler T M, et al. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res, 2003, 9:4792-4801.
3. Taylor R A, Risbridger G P. Prostatic tumor stroma: a key player in cancer progression. Current Cancer Drug Targets, 2008, 8: 490-497.
4. Karlou M, Tzelepi V, Efstathiou E. Therapeutic targeting of the prostate cancer microenvironment. Nat Rev Urol, 2010, 7:494-509.
5. Tomas D, Krulsin R. The potential value of (myo) fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma. The Prolate, 2004:324-331.
6. Tomas D, Spajic R, Milosevic M, et al. Intensity of stromal shanges predicts biochemical recurrence-free surival in prostatic carcinoma. Scandinavicn J Urol Nephrol, 2010, 44:284-290.
7. 2010, 90:2811-2814.
8. 2011, 91:2247-2249.
9. 2010, 90:2809-2810.
10. 2010, 90:2980-2983.
11. 2010, 90:937-939.